böbrek kanserinin gelişliminde arsenik ve karsinojenik mutasyonlari{dotless}n rolü

Translated title of the contribution: Renal cell cancer, environmental arsenic exposure and carcinogenic mutations

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Malignant tumors of the kidney accounts for approximately 2-3% of the all new primary cancers cases diagnosed in the US, with an estimated 60.000 cases occurring annually. Current epidemiological studies provide convincing evidence linking environmental arsenic exposure to an elevated risk of renal cell carcinoma (RCC). High levels of arsenic leaching from natural underground sources have contaminated newly drilled wells, leading to cancers of the skin, lung, liver, kidney, and bladder. This link has been the basis for regulatory actions. In 2002, the US Environmental Protection Agency (EPA) lowered the maximum contaminant level for the amount of arsenic allowed in drinking water from 50 ppb to 10 ppb (10 μL). In addition, recent molecular biology research on familial kidney cancer syndromes indicate that inactivation mutation in VHL tumor suppressor gene contributes to clear cell RCC development. Future studies using animal models are needed to explain genetic susceptibility in VHL mutations and carcinogenic effect of arsenic exposure.

Original languageUndefined
Pages (from-to)62-66
Number of pages5
JournalUHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
Volume22
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Environmental Exposure
Arsenic
Renal Cell Carcinoma
Mutation
Kidney
United States Environmental Protection Agency
Kidney Neoplasms
Skin Neoplasms
Genetic Predisposition to Disease
Tumor Suppressor Genes
Drinking Water
Epidemiologic Studies
Molecular Biology
Lung Neoplasms
Neoplasms
Urinary Bladder
Animal Models
Liver
Research

Keywords

  • Arsenic
  • Environmental exposure
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

@article{a40c9dde513541789a9b8029b59d79d2,
title = "b{\"o}brek kanserinin gelişliminde arsenik ve karsinojenik mutasyonlari{dotless}n rol{\"u}",
abstract = "Malignant tumors of the kidney accounts for approximately 2-3{\%} of the all new primary cancers cases diagnosed in the US, with an estimated 60.000 cases occurring annually. Current epidemiological studies provide convincing evidence linking environmental arsenic exposure to an elevated risk of renal cell carcinoma (RCC). High levels of arsenic leaching from natural underground sources have contaminated newly drilled wells, leading to cancers of the skin, lung, liver, kidney, and bladder. This link has been the basis for regulatory actions. In 2002, the US Environmental Protection Agency (EPA) lowered the maximum contaminant level for the amount of arsenic allowed in drinking water from 50 ppb to 10 ppb (10 μL). In addition, recent molecular biology research on familial kidney cancer syndromes indicate that inactivation mutation in VHL tumor suppressor gene contributes to clear cell RCC development. Future studies using animal models are needed to explain genetic susceptibility in VHL mutations and carcinogenic effect of arsenic exposure.",
keywords = "Arsenic, Environmental exposure, Renal cell carcinoma",
author = "Bekir Tanriover",
year = "2012",
doi = "10.4999/uhod.11079",
language = "Undefined",
volume = "22",
pages = "62--66",
journal = "UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi",
issn = "1306-133X",
publisher = "UHOD - Uluslararasi Hematoloji Onkoloji Dergisi",
number = "1",

}

TY - JOUR

T1 - böbrek kanserinin gelişliminde arsenik ve karsinojenik mutasyonlari{dotless}n rolü

AU - Tanriover, Bekir

PY - 2012

Y1 - 2012

N2 - Malignant tumors of the kidney accounts for approximately 2-3% of the all new primary cancers cases diagnosed in the US, with an estimated 60.000 cases occurring annually. Current epidemiological studies provide convincing evidence linking environmental arsenic exposure to an elevated risk of renal cell carcinoma (RCC). High levels of arsenic leaching from natural underground sources have contaminated newly drilled wells, leading to cancers of the skin, lung, liver, kidney, and bladder. This link has been the basis for regulatory actions. In 2002, the US Environmental Protection Agency (EPA) lowered the maximum contaminant level for the amount of arsenic allowed in drinking water from 50 ppb to 10 ppb (10 μL). In addition, recent molecular biology research on familial kidney cancer syndromes indicate that inactivation mutation in VHL tumor suppressor gene contributes to clear cell RCC development. Future studies using animal models are needed to explain genetic susceptibility in VHL mutations and carcinogenic effect of arsenic exposure.

AB - Malignant tumors of the kidney accounts for approximately 2-3% of the all new primary cancers cases diagnosed in the US, with an estimated 60.000 cases occurring annually. Current epidemiological studies provide convincing evidence linking environmental arsenic exposure to an elevated risk of renal cell carcinoma (RCC). High levels of arsenic leaching from natural underground sources have contaminated newly drilled wells, leading to cancers of the skin, lung, liver, kidney, and bladder. This link has been the basis for regulatory actions. In 2002, the US Environmental Protection Agency (EPA) lowered the maximum contaminant level for the amount of arsenic allowed in drinking water from 50 ppb to 10 ppb (10 μL). In addition, recent molecular biology research on familial kidney cancer syndromes indicate that inactivation mutation in VHL tumor suppressor gene contributes to clear cell RCC development. Future studies using animal models are needed to explain genetic susceptibility in VHL mutations and carcinogenic effect of arsenic exposure.

KW - Arsenic

KW - Environmental exposure

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84859464526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859464526&partnerID=8YFLogxK

U2 - 10.4999/uhod.11079

DO - 10.4999/uhod.11079

M3 - Article

AN - SCOPUS:84859464526

VL - 22

SP - 62

EP - 66

JO - UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi

JF - UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi

SN - 1306-133X

IS - 1

ER -